BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 971534)

  • 1. Changes in serum and urinary myo-inositol levels in chronic glomerulonephritis.
    Pitkänen E
    Clin Chim Acta; 1976 Sep; 71(3):461-8. PubMed ID: 971534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol clearance in renal failure and in patients with normal kidney function.
    Melmed S; Lewin LM; Bank H
    Am J Med Sci; 1977; 274(1):55-9. PubMed ID: 900156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
    Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
    Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular reabsorption of myo-inositol vs. that of D-glucose in rat kidney in vivo et situ.
    Silbernagl S; Völker K; Dantzler WH
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1181-9. PubMed ID: 12736166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum and urine 1,5-anhydro-D-glucitol and myo-inositol concentrations in healthy dogs.
    Miki Y; Mori A; Hayakawa N; Niki T; Oda H; Saeki K; Sato T; Tazaki H; Ishioka K; Arai T; Sako T
    J Vet Med Sci; 2011 Sep; 73(9):1117-26. PubMed ID: 21525712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and the myo-inositol paradox.
    Loy A; Lurie KG; Ghosh A; Wilson JM; MacGregor LC; Matschinsky FM
    Diabetes; 1990 Oct; 39(10):1305-12. PubMed ID: 2210080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of myo-inositol loading in women of reproductive age.
    Groenen PM; Merkus HM; Sweep FC; Wevers RA; Janssen FS; Steegers-Theunissen RP
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):79-85. PubMed ID: 12542915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.
    Kawa JM; Przybylski R; Taylor CG
    Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.
    Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI
    Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum and urinary neopterins in patients with chronic renal disease.
    Godai K; Uemasu J; Kawasaki H
    Clin Nephrol; 1991 Sep; 36(3):141-6. PubMed ID: 1934670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
    Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
    Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance ratios of amylase and isoamylase to creatinine in renal disease.
    Pasternack A; Klockars M
    Clin Nephrol; 1978 Jan; 9(1):25-8. PubMed ID: 630741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a sensitive myo-inositol analyser using a liquid chromatograph with a post-label fluorescence detector.
    Inamoto Y; Hiraga Y; Hanai T; Kinosita T
    Biomed Chromatogr; 1995; 9(3):146-9. PubMed ID: 7655303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of myo-inositol transport causes acute renal failure with selective medullary injury in the rat.
    Kitamura H; Yamauchi A; Sugiura T; Matsuoka Y; Horio M; Tohyama M; Shimada S; Imai E; Hori M
    Kidney Int; 1998 Jan; 53(1):146-53. PubMed ID: 9453011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of glomerular filtration rate and hypoalbuminaemia to renal glucose reabsorption.
    Usberti M; Andreucci VE
    Proc Eur Dial Transplant Assoc; 1976; 12():174-82. PubMed ID: 935110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.
    Madsen S; Olgaard K; Ladefoged J
    Adv Exp Med Biol; 1977; 81():141-8. PubMed ID: 899923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylase to creatine clearance ratio in renal diseases.
    Andriulli A; Bergia R; Masoero G; Baiardi P; Pellegrino S; Tondolo M
    Gastroenterology; 1979 Jul; 77(1):86-90. PubMed ID: 447031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.